Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

Research highlights the therapeutic potential of targeting cannabinoid receptors to counter memory impairment in early ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Irritable bowel syndrome is the most common cause of chronic diarrhea and lower abdominal discomfort in North America.

the approval of COBENFY marks a transformative milestone as the first drug in over 30 years with a novel mechanism of action ...

KIST researchers discover treatment that halves hand tremors from nicotine withdrawal KIST scientists unveil innovative ...

The Thistle will open its doors next week after nearly a decade of deadlock over drug laws. The Thistle will open its doors next week after nearly a decade of deadlock over drug laws. Naloxone is ...

You might just know someone, close or distant, who has struggled with drug addiction at one point in time. It could be a distant relative or someone you went to school with, but the sheer probability ...

A top doctor has revealed which common medications taken by millions could put you at risk of a heart attack. Dr Zain Hasan, an anesthetist in California, highlighted non-steroidal anti ...